India: Covaxin, vaccine candidates against the coronavirus disease (Covid-19) being developed in India, has been approved for skin trials by the Central Drugs Standard Control Organisation .
The vaccine is made by Hyderabad-based Bharat Biotech International Limited. And the vaccine is currently being tested through an intramuscular route, where it is injected directly into the muscle. A separate clinical trial of the potential Covid-19 vaccine will now be conducted alongside through the intradermal route, that is just under the skin, the pharmaceutical regulatory body said on Saturday.
Covaxin is being developed in collaboration with the Indian Council of Medical Research (ICMR) and National Institute of Virology (NIV). They had received Drugs Controller General of India (DCGI) approval for Phase I and II human clinical trials and the trials commenced across India from July.
As per the report, the findings of the intradermal route will be analysed separately along with the current intramuscular trial.accinated.
